PMH34 LONG-TERM TREATMENT OF SCHIZOPHRENIA FOR RELAPSE PREVENTION (LASER)- 6-MONTH OUTCOMES IN PATIENTS STARTED ON RISPERIDONE LONG-ACTING INJECTABLE IN GERMANY—DATA FROM THE E-STAR DATABASE
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67780-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)67780-7/fulltext
Title :
PMH34 LONG-TERM TREATMENT OF SCHIZOPHRENIA FOR RELAPSE PREVENTION (LASER)- 6-MONTH OUTCOMES IN PATIENTS STARTED ON RISPERIDONE LONG-ACTING INJECTABLE IN GERMANY—DATA FROM THE E-STAR DATABASE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67780-7&doi=10.1016/S1098-3015(10)67780-7
First page :
Section Title :
Open access? :
No
Section Order :
379